Radiotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Radiotherapy, including details on cancer treatment, side effects.

Volume 5 (2008), Issue 3 (March)

1. The impact of treatment choice for localized prostate cancer on response to phosphodiesterase inhibitors.
   J Urol, 179(3): 1072-6; discussion 1076. [Abstract] [Full-text]
2. Accuracy of pedicle screw insertion in the cervical spine for internal fixation using frameless stereotactic guidance.
   J Neurosurg Spine, 8(3): 237-45. [Abstract] [Full-text]
3. Targeted molecular imaging in oncology: focus on radiation therapy.
   Semin Radiat Oncol, 18(2): 136-48. [Abstract] [Full-text]
4. Genetic markers for prediction of normal tissue toxicity after radiotherapy.
   Semin Radiat Oncol, 18(2): 126-35. [Abstract] [Full-text]
5. Intensity-modulated radiation therapy dose prescription, recording, and delivery: patterns of variability among institutions and treatment planning systems.
   J Natl Cancer Inst, 100(5): 300-7. [Abstract] [Full-text]
6. Complete response of CNS-involved olfactory neuroendocrine tumor using multimodal therapy.
   Onkologie, 31(3): 119-21. [Abstract] [Full-text]
7. A prospective longitudinal study of cosmetic outcome in immediate latissimus dorsi breast reconstruction and the influence of radiotherapy.
   Ann Surg Oncol, 15(4): 1081-91. [Abstract] [Full-text]
8. A cost comparison of two strategies for treating stage IB2 cervical cancer.
   Int J Gynecol Cancer, 18(2): 274-8. [Abstract] [Full-text]
9. Cognitive impairment in rats after long-term exposure to GSM-900 mobile phone radiation.
   Bioelectromagnetics, 29(3): 219-32. [Abstract] [Full-text]
10. Boron neutron capture therapy for glioblastoma.
    Cancer Lett, 262(2): 143-52. [Abstract] [Full-text]
11. Total skin electron beam therapy may be associated with improvement of peripheral blood disease in Sézary syndrome.
    J Am Acad Dermatol, 58(4): 592-5. [Abstract] [Full-text]
12. Evaluation of tumour response after gamma knife radiosurgery for residual vestibular schwannomas based on MRI morphological features.
    J Neurol Neurosurg Psychiatry, 79(4): 431-6. [Abstract] [Full-text]
13. What is the value of emission tomography studies in patients with a primary glioblastoma multiforme treated by 192Ir brachytherapy?
    Acta Neurochir (Wien), 150(4): 345-9. [Abstract] [Full-text]
14. A dosimetric comparison between two intensity-modulated radiotherapy techniques: tomotherapy vs dynamic linear accelerator.
    Br J Radiol, 81(964): 333-40. [Abstract] [Full-text]
15. Re-defining rectal volume and DVH for analysis of rectal morbidity risk after radiotherapy for early prostate cancer.
    Br J Radiol, 81(964): 327-32. [Abstract] [Full-text]
16. An investigation into methods of IMRT planning applied to breast radiotherapy.
    Br J Radiol, 81(964): 311-22. [Abstract] [Full-text]
17. A comparison between cobalt and linear accelerator-based treatment plans for conformal and intensity-modulated radiotherapy.
    Br J Radiol, 81(964): 304-10. [Abstract] [Full-text]
18. Transient infiltration of neutrophils into the thymus following whole-body X-ray irradiation in IL-10 knockout mice.
    Biochem Biophys Res Commun, 369(2): 432-6. [Abstract] [Full-text]
19. A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients.
    Ann Oncol, 19(4): 769-73. [Abstract] [Full-text]
20. Potential prognostic benefits of radiotherapy as an initial treatment for patients with unresectable advanced hepatocellular carcinoma with invasion to intrahepatic large vessels.
    Oncology, 73(1): 90-7. [Abstract] [Full-text]
21. Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies.
    Lancet Oncol, 9(4): 367-75. [Abstract] [Full-text]
22. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.
    Lancet Oncol, 9(4): 331-41. [Abstract] [Full-text]
23. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.
    Lancet, 371(9618): 1098-107. [Abstract] [Full-text]
24. Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study.
    Lancet Oncol, 9(4): 342-51. [Abstract] [Full-text]
25. Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ).
    Lancet Oncol, 9(4): 352-8. [Abstract] [Full-text]

© 2004-2008 Radiotherapy Research Today. All Rights Reserved.